Jones Alexander Joseph, Campiti Vincent J, Alwani Mohamedkazim, Novinger Leah J, Tucker Brady Jay, Bonetto Andrea, Yesensky Jessica A, Sim Michael W, Moore Michael G, Mantravadi Avinash V
Department of Otolaryngology-Head and Neck Surgery Indiana University School of Medicine Indianapolis Indiana USA.
Department of Surgery Indiana University School of Medicine Indianapolis Indiana USA.
Laryngoscope Investig Otolaryngol. 2021 Jan 31;6(2):200-210. doi: 10.1002/lio2.530. eCollection 2021 Apr.
To determine if sarcopenia is a predictor of blood transfusion requirements in head and neck cancer free flap reconstruction (HNCFFR).
A single-institution, retrospective review was performed of HNCFFR patients with preoperative abdominal imaging from 2014 to 2019. Demographics, comorbidities (modified Charlson Comorbidity Index [mCCI]), skeletal muscle index (cm/m), oncologic history, intraoperative data, and 30-day postoperative complications (Clavien-Dindo score [CD]) were collected. Binary logistic regression was performed to determine predictors of transfusion.
Eighty (33.5%), 66 (27.6%), and 110 (46.0%) of n = 239 total patients received an intraoperative, postoperative, or any perioperative blood transfusion, respectively. Sixty-two (25.9%) patients had sarcopenia. Patients receiving intraoperative transfusions had older age ( = .035), more frequent alcoholism ( = .028) and sarcopenia ( < .001), greater mCCI ( < .001), lower preoperative hemoglobin ( < .001), reconstruction with flaps other than forearm ( = .003), and greater operative times ( = .001), intravenous fluids ( < .001), and estimated blood loss (EBL, < .001). Postoperative transfusions were associated with major complications (CD ≥ 3; < .001). Multivariate regression determined sarcopenia ( = .023), mCCI ( = .013), preoperative hemoglobin ( = .002), operative time ( = .036), and EBL ( < .001) as independent predictors of intraoperative transfusion requirements. Postoperative transfusions were predicted by preoperative hemoglobin ( = .007), osseous flap ( = .036), and CD ≥ 3 ( < .001). A perioperative transfusion was predicted by sarcopenia ( = .021), preoperative hemoglobin ( < .001), operative time ( = .008), and CD ≥ 3 ( = .018).
Sarcopenia is associated with increased blood transfusions in HNCFFR. Patients should be counseled preoperatively on the associated risks, and the increased blood product requirement should be accounted in resource-limited scenarios.
确定肌肉减少症是否为头颈部癌游离皮瓣重建术(HNCFFR)中输血需求的预测指标。
对2014年至2019年接受术前腹部影像学检查的HNCFFR患者进行单机构回顾性研究。收集人口统计学资料、合并症(改良Charlson合并症指数[mCCI])、骨骼肌指数(cm/m)、肿瘤病史、术中数据及术后30天并发症(Clavien-Dindo评分[CD])。采用二元逻辑回归分析确定输血的预测指标。
239例患者中,分别有80例(33.5%)、66例(27.6%)和110例(46.0%)接受了术中、术后或围手术期输血。62例(25.9%)患者存在肌肉减少症。接受术中输血的患者年龄较大(P = .035)、酗酒更频繁(P = .028)且存在肌肉减少症(P < .001)、mCCI更高(P < .001)、术前血红蛋白水平更低(P < .001)、采用前臂以外的皮瓣进行重建(P = .003)、手术时间更长(P = .001)、静脉输液量更多(P < .001)以及估计失血量(EBL,P < .001)。术后输血与严重并发症(CD≥3;P < .001)相关。多因素回归分析确定肌肉减少症(P = .023)、mCCI(P = .013)、术前血红蛋白(P = .002)、手术时间(P = .036)和EBL(P < .001)为术中输血需求的独立预测指标。术前血红蛋白(P = .007)、骨皮瓣(P = .036)和CD≥3(P < .001)可预测术后输血情况。肌肉减少症(P = .021)、术前血红蛋白(P < .001)、手术时间(P = .008)和CD≥3(P = .018)可预测围手术期输血情况。
肌肉减少症与HNCFFR中输血增加有关。应在术前向患者告知相关风险,在资源有限的情况下应考虑到血液制品需求增加的情况。
4级。